PACDNA LLC
Natick, MA · Biotech · Private
Brushield™ conjugate, a nucleic acid therapeutic platform that enhances antisense oligonucleotide stability, cellular uptake, and tumor accumulation for KRAS-targeting cancer therapeutics
- Grants
- $2.4M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent | $400,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent | $1,030,054 | |
| Federal grant | Department of Health and Human Services · Phase II · Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent | $988,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3159 | GENEXGEN INC | — | — |
| 3160 | Basis | — | — |
| 3161 | SYSTEM BIOSCIENCES, LLC (SBI) | — | — |
| 3162 | PACDNA LLC | — | — |
| 3163 | ANTEL BIOSYSTEMS, INC | — | — |
| 3164 | TORRALVA MEDICAL THERAPUETICS LLC | — | — |
| 3165 | Smart Biomolecules, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.